NewAmsterdam Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:NAMS Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
26 Mar 24	BuyUS$181,224	Frazier Life Sciences Management, LP	Company	8,429	US$21.50
13 Feb 24	BuyUS$95,000	Louis Lange	Individual	5,000	US$19.00
11 Aug 23	BuyUS$12,915,679	Frazier Life Sciences Management, LP	Company	1,259,902	US$10.25
09 Jun 23	BuyUS$25,000,000	Bain Capital Life Sciences Investors, LLC	Company	2,173,913	US$11.50
09 Jun 23	BuyUS$7,499,990	Forbion Capital Partners B.V.	Company	652,173	US$11.50
07 Jun 23	BuyUS$14,999,991	Frazier Life Sciences Management, LP	Company	1,304,347	US$11.50

Insider Buying: NAMS insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.2%.

Top 25 shareholders own 84.38% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.6%	Frazier Life Sciences Management, LP	12,140,134	US$260.3m	0.07%	12.18%
13.3%	Forbion Capital Partners B.V.	11,831,461	US$253.7m	0%	40.31%
11.7%	Bain Capital Life Sciences Investors, LLC	10,473,913	US$224.6m	0%	21.22%
8.99%	Viking Global Investors LP	8,024,565	US$172.0m	0%	0.62%
8.81%	RA Capital Management, L.P.	7,864,000	US$168.6m	-12.6%	2.26%
5.5%	Amgen Ventures	4,910,000	US$105.3m	0%	81.04%
4.55%	The Morningside Group Limited	4,060,923	US$87.1m	0%	12.13%
3.21%	Medicxi Ventures (UK) LLP	2,869,565	US$61.5m	0%	15.93%
2.8%	Forbion International Management B.V.	2,498,438	US$53.6m	0%	no data
1.7%	BVF Partners L.P.	1,521,948	US$32.6m	0%	0.81%
1.55%	Goldman Sachs Group, Investment Banking and Securities Investments	1,384,321	US$29.7m	0%	0.02%
1.55%	GMT Capital Corp.	1,383,800	US$29.7m	0%	0.78%
1.49%	Millennium Management LLC	1,326,103	US$28.4m	26.9%	0.03%
1.46%	Adage Capital Management, L.P.	1,300,000	US$27.9m	8.33%	0.05%
0.91%	Michael Davidson	808,563	US$17.3m	0%	no data
0.55%	Jennison Associates LLC	489,125	US$10.5m	0%	0.01%
0.48%	BioGeneration Ventures B.V.	427,831	US$9.2m	0%	100.0%
0.42%	Eversept Partners, L.P.	374,404	US$8.0m	-43.3%	0.69%
0.34%	Parkman Healthcare Partners LLC	300,750	US$6.4m	20.8%	0.89%
0.31%	AXA Investment Managers S.A.	276,328	US$5.9m	-2.36%	0.01%
0.3%	Opaleye Management Inc.	265,388	US$5.7m	0%	1.45%
0.27%	FMR LLC	243,700	US$5.2m	0%	no data
0.26%	Johannes Jacob Kastelein	228,881	US$4.9m	0%	no data
0.22%	Ensign Peak Advisors, Inc.	191,956	US$4.1m	-56.2%	0.01%
0.14%	Affinity Asset Advisors, LLC	125,000	US$2.7m	0%	0.64%